Understand the source comparison
Standard Dosing Protocol vs Individual Titration Needs
The standard LIPO-C dosing protocol in 2026 is 1mL weekly subcutaneous injection, using a formulation that provides methionine (25mg), inositol (50mg), choline (50mg), and optionally L-carnitine (100mg) and cyanocobalamin (1000mcg). This is the baseline protoc
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The standard LIPO-C dosing protocol in 2026 is 1mL weekly subcutaneous injection, using a formulation that provides methionine (25mg), inositol (50mg), choline (50mg), and optionally L-carnitine (100mg) and cyanocobalamin (1000mcg). This is the baseline protocol for metabolic support and general hepatic health maintenance. Patients with diagnosed NAFLD, elevated liver enzymes (ALT >40 U/L, AST >35 U/L), or metabolic syndrome often titrate to 2mL weekly under medical supervision. The higher dose doubles lipotropic substrate availability without exceeding the liver's capacity to utilise these compounds.
- Titration is individualised based on lipotropic response markers: liver enzyme normalisation (ALT, AST, GGT), body composition changes (reduction in visceral adipose tissue), and subjective energy improvements. Some patients respond robustly to 1mL weekly and see measurable ALT reduction within 4–6 weeks. Others require 2mL weekly to produce the same effect. The ceiling is 2mL weekly. Doses above this threshold do not produce proportional benefit and may increase homocysteine accumulation from excess methionine metabolism.
- Injection frequency matters as much as dose. LIPO-C is administered weekly because lipotropic compounds have relatively short half-lives and hepatic lipid turnover operates on a multi-day cycle. Methionine is metabolised within 24–48 hours, choline is incorporated into phospholipids within 48–72 hours, and inositol cycles through phosphatidylinositol turnover over 3–5 days. Weekly dosing ensures continuous lipotropic substrate availability without requiring daily injections. Twice-weekly protocols (0.5mL per injection) are sometimes used in clinical settings for patients who report better subjective response to divided dosing, but the total weekly volume remains 1mL.
- Our experience working with patients on structured lipotropic protocols shows that the reconstitution step is where most errors occur. Not the injection itself. Lipotropic formulations are typically supplied as lyophilised powder requiring reconstitution with bacteriostatic water before use. The lipotropic compounds are hygroscopic and degrade rapidly when exposed to moisture or heat. Reconstituting with non-bacteriostatic water or storing reconstituted solution at room temperature can reduce potency by 40–60% within one week.